Summary of the results of the cost–utility analysis for a model cohort of patients, N = 1000
| No RDC | RDC | Difference (95% CI) | |
|---|---|---|---|
| 2.78 patients per clinic | |||
| Cost | £934 156 | £1 207 651 | £273 494 (−£445 641 to £747 343) |
| QALY | 1416 | 1425 | 9.20 (−204 to 201) |
| ICER (cost per QALY gained) | £29 732 | ||
| 4 patients per clinic | |||
| Cost | £934 156 | £917 826 | −£16 330 (−£713 924 to £448 358) |
| QALY | 1416 | 1425 | 9.20 (−204 to 201) |
| ICER (cost per QALY gained) | −£1775 (outperforms) | ||
| 5 patients per clinic | |||
| Cost | £934 156 | £785 836 | −£148 320 (−£839 771 to £312 218) |
| QALY | 1416 | 1425 | 9.20 (−204 to 201) |
| ICER (cost per QALY gained) | −£16 124 (outperforms) |
ICER = incremental cost-effectiveness ratio. QALY = quality-adjusted life year. RDC = rapid diagnosis centre.